Structure-function relationships of bacterial endotoxins: Contribution to microbial sepsis

Infectious Disease Clinics of North America

Volumn 13, Issue 2, 1999, Pages 313-340

  Morrison, D C ^a   Silverstein, R ^a   Luchi, M ^a   Shnyra, A ^a  

^a ST LUKE S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE;

CHEMICAL STRUCTURE; GRAM NEGATIVE BACTERIUM; INFLAMMATION; MACROMOLECULE; MOLECULAR INTERACTION; NONHUMAN; REVIEW; SEPSIS; STRUCTURE ACTIVITY RELATION;

EID: 0032999383     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70077-5     Document Type: Article

References (121)

1. K. Amano E. Ribi J.L. Cantrell Structural requirements of endotoxic glycolipid for antitumor and toxic activity Journal of Biochemistry 93 5 1983 1391
2. C.R. Amura R. Silverstein D.C. Morrison Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies Infect Immun 66 1998 5372
3. M. Arditi L. Ables R. Yogev Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone J Infect Dis 160 1989 1005
4. H. Aschauer A. Grob J. Hildebrandt Highly purified lipid X is devoid of immunostimulatory activity. Isolation and characterization of immunostimulating contaminants in a batch of synthetic lipid X J Biol Chem 265 16 1990 9159
5. B. Beutler N. Krochin I.W. Milsark Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance Science 232 1986 977
6. Bollaert P.-E. C. Charpentier B. Levy Reversal of late septic shock with supraphysiologic doses of hydrocortisone Crit Care Med 26 1998 645
7. K. Brandenburg H. Mayer M.H. Koch Influence of the supramolecular structure of free lipid A on its biological activity Eur J Biochem 218 2 1993 555
8. P. Brandtzaeg R. Ovsteboo P. Kierulf Compartmentalization of lipopolysacharide production correlates with clinical presentation in meningococcal disease J Infect Dis 166 1992 650
9. S.E. Bucklin D.C. Morrison Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis J Infect Dis 172 1995 1519
10. J.G. Cannon Endotoxin and cytokine responses in human volunteers Ryan J.L. Morrison D.C. Immunopharmacology and Pathophysiology, vol II (Bacterial Endotoxic Lipopolysaccharides) 1992 CRC Press Boca Raton, FL 311
11. J.M. Chiller B.M. Skidmore D.C. Morrison Relationship of lipopolysaccharide structure to its function in mitogenesis and adjuvanticity Proc Natl Acad Sci U S A 70 1973 212
12. W.J. Christ O. Asano A.L. Robidoux E5531, a pure endotoxin antagonist of high potency Science 268 5207 1995 80
13. R.L. Danner P.Q. Eichacker M.E. Doerfler Therapeutic trial of lipid X in a canine model of septic shock J Infect Dis 167 2 1993 378
14. S.J. DeKimpe K.M. Kangatharan C. Thiemermann The cell wall components of peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure Proc Natl Acad Sci U S A 92 1995 10359
15. Z.Z. Din P. Mukerjee M. Kastowsky Effect of pH on solubility and ionic state of lipopolysaccharide obtained from the deep rough mutant of Escherichia coli Biochemistry 32 1993 4579
16. A.H. Ding F. Porteu E. Sanchez Shared actions of endotoxin and taxol on TNF receptors and TNF release Science 248 1990 370
17. A.S. Dofferhoff J.H. Nijland de Vries Hospers H.G. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: An in vitro and in vivo study Scand J Infect Dis 23 1991 745
18. Duncan R.L. Jr J. Hoffman V.L. Tesh Immunological activity of lipopolysaccharides released from macrophages after the uptake of intact E. coli in vitro J Immunol 136 1986 2924
19. M.A. Freudenberg C. Galanos The metabolic fate of endotoxins Prog Clin Biol Res 272 1988 63
20. M.A. Freudenberg C. Galanos Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice Infect Immun 59 1991 2110
21. J.T.M. Frieling J.A. Mulder T. Hendriks Antimicrob Agents Chemother 41 1997 1439
22. C. Galanos M.A. Freudenberg Tumor necrosis factor mediates endotoxin shock: effects of antibodies and cortisone Bonavida B. Granger G. Tumor Necrosis Factor, Structure, Mechanism of Action, Role in Disease and Therapy 1990 Karger Basel 187
23. C. Galanos M.A. Freudenberg T. Katschinski Tumor necrosis factor and host response to endotoxin Ryan J.L. Morrison D.C. Bacterial Endotoxic Polysaccharides vol 2 1992 CRC Press Boca Raton, FL 75
24. C. Galanos M.A. Freudenberg W. Reutter Galactosamine-induced sensitization to the lethal effects of endotoxin Proc Natl Acad Sci U S A 76 1979 5939
25. C. Galanos V. Lehmann O. Luderitz Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A Eur J Biochem 140 2 1984 221
26. C. Galanos O. Luderitz E.T. Rietschel Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities Eur J Biochem 148 1 1985 1
27. J.F. Galpine Chloramphenicol in typhoid fever BMJ 2 1949 1047
28. D.T. Golenbock R.Y. Hampton N. Qureshi Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes J Biol Chem 266 29 1991 19490
29. J.C. Gonzalez D.C. Johnson D.C. Morrison Endogenous and exogenous glucocorticoids have different roles in modulating endotoxin lethality in d -galactosamine-sensitized mice Infect Immun 61 1993 970
30. G.W. Goodman B.M. Sultzer Endotoxin protein is a mitogen and polyclonal activator of human B lymphocytes J Exp Med 149 1979 713
31. G.E. Grau D.N. Maennel TNF inhibition and sepsis — sounding a cautionary note Nat Med 3 1997 1193
32. D. Gupta T.N. Kirkland Viriyakosol CD14 is a cell-activating receptor for bacterial peptidoglycan J Biol Chem 271 1996 23310
33. J.L. Hartwell M.J. Shear Adams J.R. Jr Chemical treatment of tumors, VII. Nature of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrates J Natl Cancer Inst 4 1943 107
34. T. Horii M. Kobayashi K. Sato An in vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli J Antimicrob Chemother 41 1998 435
35. M. Imoto H. Yoshimura N. Sakaguchi Total synthesis of Escherichia coli lipid A Tetrahedr Lett 26 1985 1545
36. M. Imoto H. Yoshimura M. Yamamoto Chemical synthesis of phosphorylated tetraacyl disaccharide corresponding to a precursor of lipid A Tetrahedr Lett 25 1984 2667
37. J.J. Jackson H. Kropp Beta-lactam antibiotic-induced release of free endotoxin: In vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime J Infect Dis 165 1992 1033
38. J.J. Jackson H. Kropp Differences in mode of action of beta-lactam antibiotics influence morphology. LPS release and in vivo antibiotic efficacy Journal of Endotoxin Research 3 1996 201
39. B.W. Jarvis H. Lichenstein N. Qureshi Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS Infect Immun 65 8 1997 3011
40. D.C. Johnson M.A. Freudenberg F. Jia Contribution of tumor necrosis factor- α and glucocorticoid in hydrazine sulfate-mediated protection against endotoxin lethality Circulatory Shock 43 1994 1
41. S.S. Katz K. Chen S. Chen Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin Infect Immun 64 1996 3592
42. T. Kawata J.R. Bristol J.R. Rose Anti-endotoxin activity of a novel synthetic lipid A analog Prog Clin Biol Res 392 1995 499
43. K.M. Kengatharan S.J. DeKimpe C. Robson Mechanism of gram-positive shock: Identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure J Exp Med 188 1998 305
44. A. Kiani A. Tschiersch E. Gaboriau Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients Blood 90 4 1997 1673
45. J.W. Killion D.C. Morrison Mechanisms of murine salmonellosis immunity induced by immunization with lipopolysaccharide-lipid A-associated protein complexes in C3H/HeJ mice FEMS Immunol Med Microbiol 47 1988 41
46. F. Kirikae T. Kirikae N. Qureshi CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages Infect Immun 63 1995 486
47. T. Kirikae F.U. Schade U. Zahringer The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction FEMS Immunol Med Microbiol 8 1994 13
48. N.L. Kovach E. Yee R.S. Munford Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo J Exp Med 172 1 1990 77
49. H. Kumada Y. Haishima T. Umemoto Structural study on the free lipid A isolated from lipopolysacchiride of Porphyromonas gingivalis J Bacteriol 177 8 1995 2098
50. S. Kusumoto M. Yamamoto T. Shiba Chemical synthesis of lipid X and lipid Y, acylglucosamine-1-phosphates isolated from Escherichia coli mutants Tetrahedr Lett 25 1984 3727
51. C. Lam E. Schutze E. Liehl Effect of SDZ MRL 953 on the survival of mice with advanced sepsis that cannot be cured by antibiotics alone Antimicrob Agents Chemother 35 3 1991 506
52. C. Lam E. Schutze J. Hildebrandt SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis Antimicrob Agents Chemother 35 3 1991 500
53. M.C. Leeson Y. Fujihara D.C. Morrison Evidence for lipopolysacharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria Infect Immun 62 1994 4975
54. M.C. Leeson D.C. Morrison Induction of proinflammatory responses in human monocytes by particulate and soluble forms of lipopolysaccharide Shock 2 1994 235
55. H. Loppnow L. Brade H. Brade Induction of human interleukin 1 by bacterial and synthetic lipid A Eur J Immunol 16 10 1986 1263
56. H. Loppnow H. Brade I. Durrbaum IL-1 induction-capacity of defined lipopolysaccharide partial structures J Immunol 142 9 1989 3229
57. I. Matot C.L. Sprung Corticosteroids in septic shock: Resurrection of the last rites? Crit Care Med 26 1998 627
58. C.L. Manthey S.N. Vogel Elimination of trace endotoxin protein from rough chemotype LPS J Endotoxin Research 1 1994 84
59. G.U. Meduri A.S. Headley E. Golden Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome — a randomized controlled trial JAMA 280 1998 159
60. G.U. Meduri S. Kanangat Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: Time for a critical reappraisal Crit Care Med 26 1998 630
61. D.C. Morrison S.J. Betz D.M. Jacobs Isolation and characterization of the fraction of LPS responsible for mitogenesis of C3H/HeJ spleen cells J Exp Med 144 1976 840
62. D.C. Morrison S.E. Bucklin M.C. Leeson Contribution of soluble endotoxin released from gram-negative bacteria by antibiotics to the pathogenesis of experimental sepsis in mice J Endotoxin Research 3 1996 237
63. D.C. Morrison C.A. Dinarello R.S. Munford Bacterial endotoxins and pathogenesis of gram-negative infections: Current status and future direction J Endotoxin Research 1 1994 71
64. D.C. Morrison D.M. Jacobs Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides Immunochemistry 13 1976 813
65. D.C. Morrison L.F. Kline Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides J Immunol 118 1977 362
66. R.S. Munford C.L. Hall Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme Science 234 1986 203
67. M.M. Mustafa J. Mertsola O. Ramilo Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy J Infect Dis 160 1989 891
68. M.M. Mustafa O. Ramilo J. Mertsola Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis J Infect Dis 160 1989 181
69. M. Nakano T. Kirikae Biological characterization of Pseudomonas aeruginosa endotoxin released by antibiotic treatment in vitro J Endotoxin Research 3 1995 195
70. H. Nikaido Galactose-sensitive mutants of Salmonella . I. Metabolism of galactose Biochim Biophys Acta 48 1961 460
71. H. Nikaido Studies on the biosynthesis of cell wall polysacharide in mutant strains of Salmonella II. 48 1962 Proc Natl Acad Sci U S A Washington, DC 1542
72. M. Norimatsu D.C. Morrison Correlation of antibiotic-induced endotoxin release and cytokine production in Escherichia coli -inoculated mouse whole blood ex vivo J Infect Dis 177 1998 1302
73. C.M. Odio I. Faingezicht M. Paris The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis N Engl J Med 324 1991 1525
74. Opal SM, Cohen J: Clinical gram-positive sepsis: Does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med, in press
75. S.M. Opal D.L. Horn J.E. Palardy The in vivo significance of antibiotic-induced endotoxin release in experimental gram-negative sepsis J Endotoxin Research 3 1996 245
76. M. Parant C. LeContel F. Parant Influence of endogenous glucocorticoid on endotoxin-induced production of circulating TNF- α Lymphokine Cytokine Res 10 1991 265
77. T.H. Pohlman R.S. Munford J.M. Harlan Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro J Exp Med 165 1987 2393
78. Prins J.M. van Agtmael M.A. E.J. Kuijper Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: A double-blind study comparing imipenem and ceftazidime J Infect Dis 172 1995 886
79. R.A. Proctor J.A. Will K.E. Burhop Protection of mice against lethal endotoxemia by a lipid A precursor Infect Immun 52 3 1986 905
80. N. Qureshi P. Mascagni E. Ribi Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination J Biol Chem 260 9 1985 5271
81. N. Qureshi K. Takayama E. Ribi Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium J Biol Chem 257 19 1982 11808
82. N. Qureshi B. Jarvis K. Takayama Natural and synthetic LPS and lipid A analogs or partial structures that antagonize or induce tolerance to LPS Prog Clin Biol Res 397 1998 289
83. N. Qureshi J. Hofman K. Takayama Diphosphoryl lipid A from Rhodobacter sphaeroides : A novel lipopolysaccharide antagonist Morrison D.C. Ryan J.L. Novel Therapeutic Strategies in the Treatment of Sepsis 1996 Marcel Dekker New York 111
84. D. Remick P. Manohar G. Bolgos Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture Shock 4 1995 89
85. E.T. Rietschel H. Gottert O. Luderitz Nature and linkages of the fatty acids present in the lipid A component of Salmonella lipopolysaccharides Eur J Biochem 28 1972 166
86. E.T. Rietschel Y.B. Kim D.W. Watson Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin Infect Immun 8 1973 173
87. E.T. Rietschel T. Kirikae F.U. Schade The chemical structure of bacterial endotoxin in relation to bioactivity Immunobiology 187 3 – 5 1993 169
88. E.T. Rietschel T. Kirikae W. Feist Molecular Aspects of the Chemistry and Biology of Endotoxin Sies H. Flohe L. Zimmer G. Molecular Aspects of Inflammation 1991 Springer-Verlag Berlin, Heidelberg 207
89. E.T. Rietschel O. Westphal Endotoxin: Historical Perspectives Brade H. Opal S.M. Vogel S. Endotoxin in Health and Disease 1999 Marcel Dekker New York
90. R.S. Rosenthal R. Dziarski Isolation of peptidoglycan and soluble peptidoglycan fragments Methods Enzymol 235 1994 253
91. K. Sato Y.C. Yoo A. Fukushima A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia Infect Immun 63 8 1995 2859
92. C.M. Schneider D. Huzly C. Vetter Tumor necrosis factor alpha and interleukin 6 release induced by antibiotic killing of Pseudomonas aeruginosa and Staphylococcus aureus Eur J Clin Microbiol Infect Dis 16 1997 467
93. B.S. Schwartz M.C. Monroe J.D. Bradshaw Endotoxin-induced production of plasminogen activator inhibitor by human monocytes is autonomous and can be inhibited by lipid X Blood 73 8 1989 2188
94. U. Seydel Molecular basis of endotoxin toxicity Ann N Y Acad Sci 851 1998 406
95. U. Seydel K. Brandenburg E.T. Rietschel A case for an endotoxic conformation Prog Clin Biol Res 388 1994 17
96. J.L. Shenep R.P. Barton K.A. Mogan Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis J Infect Dis 151 1985 1012
97. R. Silverstein P. Hannah D.C. Johnson Natural adrenocorticosteroids do not restore resistance to endotoxin in the adrenalectomized mouse Circ Shock 41 1993 162
98. R. Silverstein D.C. Johnson M. Norimatsu Glucocorticoid Control of Endotoxin Responses Morrison D.C. Endotoxin in Health and Disease 1999 Dekker New York 769 779
99. R. Silverstein M. Norimatsu D.C. Morrison Fundamental differences during gram-positive versus gram-negative sepsis become apparent during bacterial challenge of d -galactosamine-treated mice J Endotox Res 4 1997 173
100. R. Silverstein B.R. Turley C.A. Christoffersen Hydrazine sulfate protects d -galactosamine-sensitized mice against endotoxin and tumor necrosis factor lethality: Evidence of a role for the pituitary J Exp Med 173 1991 357
101. Silverstein R, Wood JG, Xue Q, et al: Post-antibiotic therapy-induced inflammatory responses contribute to mortality in experimental gram-positive and gram-negative infections [ abstract ] . In Abstracts of the 8th International Congress of Infectious Diseases, Boston, 1998, p 318
102. Silverstein R, Xue Q, Morrison DC, et al: Endogenous and exogenous glucocorticoid relationships between endotoxin and live bacterial challenge in normal and adrenalectomized mice [ abstract ] . In Abstracts, 5th Conference of the International Endotoxin Society, Santa Fe, 1998, p 137
103. W.W. Spink A.I. Braude M.R. Castenda Aureomycin therapy in human brucellosis due to Brucella melitensis JAMA 138 1948 1145
104. P.L. Stuetz H. Aschauer J. Hildebrandt Chemical synthesis of endotoxin analogues and some structure activity relationship Novotny A. Spitzer J.J. Ziegler E.J. Cellular and Molecular Aspects of Endotoxin Reactions 1991 Excerpta Medica Belle Mead, NJ 129
105. K. Takayama E. Ribi J.L. Cantrell Isolation of a nontoxic lipid A fraction containing tumor regression activity Cancer Res 41 7 1981 2654
106. K. Tanamoto U. Zahringer G.R. McKenzie Biological activities of synthetic lipid A analogs: Pyrogenicity, lethal toxicity, anticomplement activity and induction of gelation of Limulus amoebocyte lysate Infect Immun 44 1984 421
107. M.G. Tauber A.M. Shibl C.J. Hackbarth Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits J Infect Dis 156 1987 456
108. K.J. Tracey B. Beutler S.F. Lowry Shock and tissue injury induced by recombinant human cachectin Science 234 1986 470
109. K.J. Tracey Y. Fong D.G. Hesse Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 330 1987 662
110. K. Tanamoto S. Azumi Y. Haishima The lipid A moiety of porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice J Immunol 158 9 1997 4430
111. Tesh V.L. Duncan R.L. Jr D.C. Morrison The interaction of E. coli with normal human serum. I. The kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing J Immunol 137 1986 1329
112. V.L. Tesh D.C. Morrison The physical chemical characterization and biological activity of serum-released lipopolysaccharides J Immunol 141 1988 3523
113. V.L. Tesh D.C. Morrison The interaction of E. coli with normal human serum: Factors affecting the capacity of serum to mediate lipopolysacharide release Microb Pathog 4 1988 175
114. 125I-lipopolysaccharide Infect Immun 60 12 1992 5145
115. van der Poll T. S.F. Lowry Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 3 1995 1
116. Von Eschen K.B. Monophosphoryl lipid A and immunotherapy Ryan J.L. Morrison D.C. Immunopharmacology and Pathophysiology, vol II 1992 CRC Press Boca Raton, FL
117. S.W. Vukajlovich D.C. Morrison Conversion of lipopolysaccharides to molecular aggregates with uniform subunit composition: Demonstration of LPS-responsiveness in endotoxin unresponsive C3H/HeJ B-lymphocytes J Immunol 130 1983 2804
118. S.W. Vukajlovich D.C. Morrison Activation of murine spleen cells by lipid A: Negative modulation of lipid A mitogenic activity by O-antigen polysaccharide J Immunol 135 1985 2546
119. S.W. Vukajlovich J. Hoffman D.C. Morrison Activation of human serum complement by bacterial lipopolysaccharides: Structural requirements for antibody independent activation of the classical and alternative pathways Mol Immunol 24 1987 319
120. W. Weil A. Felix Weitere Untersuchungen Uber das Wesen der Fleckfieberagglutination Wien Klin Wochenschr 30 1917 1509
121. H.W. Wollenweber D.C. Morrison Synthesis and biochemical characterization of a photoactivatable, iodinatable, cleavable bacterial lipopolysaccharide derivative J Biol Chem 260 1985 15068